Correction: The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years
Leukemia. 2022 Aug;36(8):2150. doi: 10.1038/s41375-022-01639-5.NO…
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients
Ann Hematol. 2022 Sep;101(9):2053-2067. doi: 10.1007/s00277-022-04906-8.…
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
Haematologica. 2023 Jan 1;108(1):110-121. doi: 10.3324/haematol.2022.280805.ABSTRACTAxicabtagene…
Follicular lymphoma grade 3: a comprehensive review
Clin Adv Hematol Oncol. 2022 Jun;20(6):384-390.ABSTRACTFollicular…
Second-line CAR T cells for lymphomas
Lancet. 2022 Jun 18;399(10343):2247-2249. doi: 10.1016/S0140-6736(22)00790-5.NO…
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
Eur J Cancer. 2022 Aug;171:64-74. doi: 10.1016/j.ejca.2022.04.036.…
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma
Clin Lymphoma Myeloma Leuk. 2022 Sep;22(9):e844-e852. doi: 10.1016/j.clml.2022.04.024.…
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
J Clin Oncol. 2022 Sep 20;40(27):3151-3161. doi: 10.1200/JCO.21.01365.…
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
Lancet Oncol. 2022 Jul;23(7):865-875. doi: 10.1016/S1470-2045(22)00273-X.…
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
Bone Marrow Transplant. 2022 Aug;57(8):1217-1239. doi: 10.1038/s41409-022-01691-w.…
Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry
Eur J Cancer. 2022 Jul;170:10-16. doi: 10.1016/j.ejca.2022.03.019.…
Novel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era in aggressive lymphoma
Leuk Lymphoma. 2022 Sep;63(9):2041-2051. doi: 10.1080/10428194.2022.2068007.…
